Clinical trial
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP…
NCT00271557 · Scios, Inc., Industry · Completed
Key facts
| NCT number | NCT00271557 |
|---|---|
| Title | A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels |
| Official title | A Randomized, Open-Label, Active-Controlled, Multicenter Phase III Safety Study of Two Doses of NATRECOR hBNP (Nesiritide) Administered as a Continuous Infusion in the Treatment of Decompensated CHF |
| Lead sponsor | Scios, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Heart Decompensation |
| Intervention type | Drug |
| Interventions | nesiritide |
| Enrollment | 305 |
| Start date | Jan 1, 1997 |
| Completion | Dec 1, 1997 |
| First posted | Jan 2, 2006 |
| Last update posted | Mar 4, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: